Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange Detected- Added the disease term 'Hepatocellular carcinoma' and a new resource link to the Genetic and Rare Diseases Information Center. - Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check24 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check60 days agoChange DetectedA government funding/operating status notice was added, with links to cc.nih.gov and opm.gov, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check67 days agoChange DetectedAdded a glossary toggle and updated the page footer to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous entries Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4; no visible changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.